Abstract
It is critical to understand the impact of distinct policy interventions to the ongoing coronavirus disease pandemic. I develop a flexible behavioral, dynamic, and sectorial epidemic policy model comprising both endogenous virus transmission and public health and citizen responses. Applicable to the full epidemic cycle including confinement, deconfinement, and resurgence, the model allows exploring the multivariate impact of distinct policy interventions, including general and targeted testing and social contact reduction efforts. Using a cross-sectional calibration to data on the ongoing coronavirus disease outbreak about reported cases and deaths, tests performed, and social interactions from six countries (South Korea, Germany, Italy, France, Sweden, and the United States), I demonstrate how early, rapid, and extensive buildup of testing and social contact reduction efforts interplay to suppress the outbreak. I then use the model to show and quantify limits to the extent of deconfinement and illustrate the critical role of targeted approaches for managing post peak deconfinement and resurgence. To aid necessary public and expert understanding of outbreak control strategies the model is accessible in the form of a web-based management flight simulator.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no external funding was received.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
all data is publicly available (sources have been referenced in the document.)
